Therapeutic applications of botulinum neurotoxins in head and neck disorders

被引:7
作者
Alshadwi, Ahmad [1 ,2 ]
Nadershah, Mohammed [3 ]
Osborn, Timothy [1 ]
机构
[1] Boston Univ, Henry M Goldman Sch Dent Med, Dept Oral & Maxillofacial Surg, Boston, MA 02118 USA
[2] King Feisal Specialist Hosp & Res Ctr, Riyadh, Saudi Arabia
[3] King Abdulaziz Univ, Dent Sch, Acad Fac, Jeddah, Saudi Arabia
关键词
Botulinum toxin; Botox; Temporomandibular disorder; Dystonia; Facial pain;
D O I
10.1016/j.sdentj.2014.10.001
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Objective: The aim of this article is to review the mechanism of action, physiological effects, and therapeutic applications of botulinum neurotoxins in the head and neck area. Study design: An extensive literature search was performed using keywords. The resulting articles were analyzed for relevance in four areas: overview on botulinum neurotoxins, the role of botulinum neurotoxins in the management of salivary secretory disorders, the role of botulinum neurotoxins in the management of facial pain, and the role of botulinum neurotoxins in head and neck movement disorders. Institutional review board approval was not needed due the nature of the study. Results: Botulinum neurotoxin therapy was demonstrated to be a valuable alternative to conventional medical therapy for many conditions affecting the head and neck area in terms of morbidly, mortality, and patient satisfaction with treatment outcomes. Conclusion: Botulinum neurotoxin therapy provides viable alternatives to traditional treatment modalities for some conditions affecting the head and neck region that have neurological components. This therapy can overcome some of the morbidities associated with conventional therapy. More research is needed to determine the ideal doses of botulinum neurotoxin to treat different diseases affecting the head and neck regions. (C) 2014 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University.
引用
收藏
页码:3 / 11
页数:9
相关论文
共 82 条
[1]   Classification and genetics of dystonia [J].
Aguiar, PMD ;
Ozelius, LJ .
LANCET NEUROLOGY, 2002, 1 (05) :316-325
[2]   Botulinum toxin for masseter hypertrophy [J].
Al-Muharraqi, Mohammed A. ;
Fedorowicz, Zbys ;
Al Bareeq, Jaffer ;
Al Bareeq, Reem ;
Nasser, Mona .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2009, (01)
[3]   Botulinum toxin in the treatment of first bite syndrome [J].
Ali, M. Jafer ;
Orloff, Lisa A. ;
Lustig, Lawrence R. ;
Eisele, David W. .
OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2008, 139 (05) :742-743
[4]   Nonsurgical management of traumatic injuries of the parotid gland and duct using type A botulinum toxin [J].
Arnaud, Sebastien ;
Batifol, Dominique ;
Goudot, Patrick ;
Yachouh, Jacques .
PLASTIC AND RECONSTRUCTIVE SURGERY, 2006, 117 (07) :2426-2430
[5]   Botulinum toxin as a biological weapon - Medical and public health management [J].
Arnon, SS ;
Schechter, R ;
Inglesby, TV ;
Henderson, DA ;
Bartlett, JG ;
Ascher, MS ;
Eitzen, E ;
Fine, AD ;
Hauer, J ;
Layton, M ;
Lillibridge, S ;
Osterholm, MT ;
O'Toole, T ;
Parker, G ;
Perl, TM ;
Russell, PK ;
Swerdlow, DL ;
Tonat, K .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (08) :1059-1070
[6]   OnabotulinumtoxinA for the Treatment of Headache [J].
Ashkenazi, Avi ;
Blumenfeld, Andrew .
HEADACHE, 2013, 53 :54-61
[7]  
Aurora SK, 2010, CEPHALALGIA, V30, P793, DOI 10.1177/0333102410364676
[8]   Efficacy of pharmacological treatment of dystonia: evidence-based review including meta-analysis of the effect of botulinum toxin and other cure options [J].
Balash, Y ;
Giladi, N .
EUROPEAN JOURNAL OF NEUROLOGY, 2004, 11 (06) :361-370
[9]   Oromandibular dystonia revisited: A review and a unique case [J].
Balasubramaniam, Ramesh ;
Rasmussen, Jared ;
Carlson, Lyle W. ;
Van Sickels, Joseph E. ;
Okeson, Jeffrey P. .
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2008, 66 (02) :379-386
[10]   REDUCED HIGH-ENERGY PHOSPHATE LEVELS IN THE PAINFUL MUSCLES OF PATIENTS WITH PRIMARY FIBROMYALGIA [J].
BENGTSSON, A ;
HENRIKSSON, KG ;
LARSSON, J .
ARTHRITIS AND RHEUMATISM, 1986, 29 (07) :817-821